Order Article Reprints

Abdelsattar S, Sweed D, Kamel HFM, Kasemy ZA, Gameel AM, Elzohry H, Ameen O, Elgizawy EI, Sallam A, Mosbeh A, et al. The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients. Biomolecules. 2023; 13(1):3. https://doi.org/10.3390/biom13010003

Abdelsattar, Shimaa, Dina Sweed, Hala F. M. Kamel, Zeinab A. Kasemy, Abdallah M. Gameel, Hassan Elzohry, Omnia Ameen, Eman Ibrahim Elgizawy, Ahmed Sallam, Asmaa Mosbeh, and et al. 2023. "The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients" Biomolecules 13, no. 1: 3. https://doi.org/10.3390/biom13010003

Abdelsattar, S., Sweed, D., Kamel, H. F. M., Kasemy, Z. A., Gameel, A. M., Elzohry, H., Ameen, O., Elgizawy, E. I., Sallam, A., Mosbeh, A., Abdallah, M. S., Khalil, F. O., Al-Amodi, H. S., & El-Hefnway, S. M. (2023). The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients. Biomolecules, 13(1), 3. https://doi.org/10.3390/biom13010003